PCM
ALAB icon

Prelude Capital Management’s Astera Labs ALAB Stock Holding History

Prelude Capital Management’s Portfolio ALAB Stock Details ALAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$832K Buy
7,591
+6,264
+472% +$892K 0.06% 347
2025
Q4 		$221K Sell
1,327
-1,185
-47% -$198K 0.02% 998
2025
Q3 		$492K Sell
2,512
-7,303
-74% -$1.2M 0.04% 510
2025
Q2 		$887K Buy
9,815
+5,389
+122% +$426K 0.09% 289
2025
Q1 		$264K Buy
+4,426
New +$409K 0.02% 766

Other funds holding ALAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
AM
Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Prelude Capital Management's ALAB Position: Q1 2026 in Review

Prelude Capital Management increased its Astera Labs (ALAB) stake by 472% in Q1 2026, buying an estimated $892K and bringing the position to 7,591 shares worth $832K. The position accounts for 0.06% of the portfolio, ranked #347.

Prelude Capital Management first reported a position in ALAB in Q1 2025 and has held it in 5 quarters since. The position peaked at $887K in Q2 2025. 703 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.

  • Prelude Capital Management held 7,591 shares of Astera Labs worth $832K as of Q1 2026.
  • Prelude Capital Management bought 6,264 Astera Labs shares in Q1 2026, an estimated $892K.
  • Astera Labs made up 0.06% of Prelude Capital Management's portfolio in Q1 2026, its #347 holding.
  • Prelude Capital Management first reported a position in Astera Labs in Q1 2025 and has held it in 5 quarters since.
  • Prelude Capital Management's Astera Labs position peaked at $887K in Q2 2025.
  • 703 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.